RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Prenatal Exposure Delayed Effects
Accession: DOID:9001234
browse the term
Definition: The consequences of exposing the FETUS in utero to certain factors, such as NUTRITION PHYSIOLOGICAL PHENOMENA; PHYSIOLOGICAL STRESS; DRUGS; RADIATION; and other physical or chemical factors. These consequences are observed later in the offspring after BIRTH.
Synonyms: exact_synonym: Late Effects, Prenatal Exposure
primary_id: MESH:D011297 ; RDO:0006410
For additional species annotation, visit the
Alliance of Genome Resources .
G
Adora1
adenosine A1 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19092996
NCBI chr13:51,042,111...51,076,913
Ensembl chr13:51,042,248...51,076,852
G
Agtr1b
angiotensin II receptor, type 1b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22728133
NCBI chr 2:105,149,020...105,224,335
Ensembl chr 2:105,149,020...105,224,295
G
Atm
ATM serine/threonine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21177254
NCBI chr 8:58,015,938...58,119,973
Ensembl chr 8:58,015,940...58,120,045
G
Bmp2
bone morphogenetic protein 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29800642
NCBI chr 3:126,335,963...126,346,771
Ensembl chr 3:126,335,863...126,346,318
G
Ccn2
cellular communication network factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21258935
NCBI chr 1:21,851,657...21,854,773
Ensembl chr 1:21,851,660...21,854,773
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15570195
NCBI chr 7:123,599,264...123,608,436
Ensembl chr 7:123,599,266...123,608,436
G
Fgf2
fibroblast growth factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19014962
NCBI chr 2:124,081,072...124,134,133
Ensembl chr 2:124,081,072...124,134,681
G
Fosb
FosB proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26411935
NCBI chr 1:80,214,691...80,221,417
Ensembl chr 1:80,214,494...80,221,710
G
Maoa
monoamine oxidase A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22340208
NCBI chr X:6,554,698...6,620,722
Ensembl chr X:6,554,698...6,620,722
G
Myod1
myogenic differentiation 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21258934
NCBI chr 1:102,396,538...102,399,248
Ensembl chr 1:102,396,538...102,399,248
G
Nrgn
neurogranin
IEP
RGD
PMID:17579784
RGD:9835426
NCBI chr 8:40,015,049...40,023,193
Ensembl chr 8:40,015,049...40,023,193
G
Ogg1
8-oxoguanine DNA glycosylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18768699
NCBI chr 4:145,282,828...145,289,367
Ensembl chr 4:145,282,797...145,289,326
G
Pon1
paraoxonase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25463530 PMID:28396702
NCBI chr 4:30,249,749...30,276,297
Ensembl chr 4:30,249,742...30,276,372
G
Sigmar1
sigma non-opioid intracellular receptor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15451042
NCBI chr 5:58,121,824...58,124,687
Ensembl chr 5:58,121,786...58,124,681
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all